Sven Mahner Selected Research

Sven Mahner Research Topics

Disease

118	Neoplasms (Cancer) 12/2022 - 10/2006
89	Ovarian Neoplasms (Ovarian Cancer) 02/2022 - 07/2009
44	Breast Neoplasms (Breast Cancer) 03/2022 - 10/2006
30	Ovarian Epithelial Carcinoma 01/2022 - 07/2009
20	Vulvar Neoplasms (Vulvar Cancer) 01/2022 - 05/2010
18	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2022 - 01/2011
17	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2009
16	Carcinoma (Carcinomatosis) 01/2022 - 04/2012
12	Habitual Abortion (Recurrent Miscarriage) 01/2022 - 01/2018
10	Carcinogenesis 03/2021 - 10/2013
9	Spontaneous Abortion (Miscarriage) 01/2022 - 01/2018
9	Disease Progression 07/2021 - 01/2015
8	Pre-Eclampsia (Preeclampsia) 01/2022 - 07/2017
8	Ascites 01/2021 - 09/2009
7	Endometrial Neoplasms (Endometrial Cancer) 12/2022 - 03/2016
6	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022 - 07/2017
6	Circulating Neoplastic Cells 01/2021 - 01/2017
6	Residual Neoplasm 01/2020 - 02/2009
5	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2019 - 12/2015
5	Neutropenia 01/2018 - 01/2015
4	Inflammation (Inflammations) 01/2022 - 03/2020
4	Lymphatic Metastasis 01/2021 - 05/2010
4	Alopecia (Baldness) 04/2020 - 01/2015
4	Peritoneal Neoplasms 11/2018 - 04/2013
3	Endometriosis 10/2021 - 07/2017
3	Pain (Aches) 08/2021 - 05/2019
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 03/2015
3	Rupture 05/2019 - 07/2013
3	Thrombocytopenia (Thrombopenia) 01/2018 - 12/2016
2	Pulmonary Embolism 03/2022 - 01/2018
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2022 - 10/2021

Drug/Important Bio-Agent (IBA)

40	PlatinumIBA 01/2022 - 01/2010
35	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2009
20	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2013
10	Estrogen ReceptorsIBA 03/2022 - 09/2012
10	Hormones (Hormone)IBA 08/2021 - 01/2017
9	ParaffinIBA 01/2022 - 02/2013
9	Messenger RNA (mRNA)IBA 11/2021 - 09/2015
8	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 09/2009
8	Dinoprostone (PGE2)FDA Link 08/2021 - 01/2018
7	Galectins (Galectin)IBA 10/2022 - 12/2015
7	EnzymesIBA 11/2021 - 01/2011
7	Gemcitabine FDA Link 10/2020 - 04/2013
6	histone H3 trimethyl Lys4IBA 01/2022 - 03/2020
6	CytokinesIBA 11/2021 - 10/2020
6	Estrogens (Estrogen)FDA Link 01/2021 - 09/2012
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 01/2015
5	AntibodiesIBA 10/2021 - 05/2010
5	Biological ProductsIBA 07/2021 - 02/2013
5	RNA (Ribonucleic Acid)IBA 07/2021 - 11/2010
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2016
5	ProstaglandinsIBA 12/2020 - 07/2017
4	CA-19-9 Antigen (CA 19-9 Antigen)IBA 12/2022 - 01/2017
4	Lysine (L-Lysine)FDA Link 11/2021 - 03/2020
4	Histones (Histone)IBA 11/2021 - 12/2017
4	GTP-Binding Proteins (G-Protein)IBA 11/2021 - 01/2018
4	CateninsIBA 06/2021 - 05/2017
4	Prostaglandin Receptors (Prostaglandin Receptor)IBA 03/2021 - 07/2017
4	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 01/2021 - 01/2020
4	Protein Isoforms (Isoforms)IBA 01/2021 - 06/2020
4	LigandsIBA 01/2021 - 01/2019
4	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2020 - 11/2017
4	Bevacizumab (Avastin)FDA Link 01/2020 - 04/2013
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2020 - 11/2017
4	niraparibIBA 12/2019 - 12/2016
4	Docetaxel (Taxotere)FDA Link 10/2018 - 09/2009
4	Carbonic Anhydrase IXIBA 01/2011 - 05/2010
3	Sialyl Lewis X AntigenIBA 12/2022 - 01/2017
3	Progesterone Receptors (Progesterone Receptor)IBA 03/2022 - 01/2019
3	Cadherins (E-Cadherin)IBA 01/2022 - 09/2015
3	TeaIBA 01/2022 - 01/2019
3	Co-Repressor ProteinsIBA 11/2021 - 01/2019
3	Small Interfering RNA (siRNA)IBA 11/2021 - 01/2020
3	Thyroid HormonesIBA 08/2021 - 02/2018
3	Pharmaceutical PreparationsIBA 07/2021 - 01/2017
3	AntigensIBA 04/2021 - 10/2018
3	Bromodeoxyuridine (BrdU)IBA 03/2021 - 03/2020
3	Mucin-1 (CA 15-3 Antigen)IBA 02/2021 - 01/2019
3	CarbohydratesIBA 01/2021 - 06/2017
3	Indicators and Reagents (Reagents)IBA 01/2021 - 07/2019
3	AnthracyclinesIBA 10/2020 - 11/2016
3	Vitamin D FDA LinkGeneric 10/2020 - 11/2017
3	Plasminogen Activator Inhibitor 1IBA 09/2020 - 11/2010
3	Formaldehyde (Formol)FDA Link 07/2020 - 09/2017
3	liposomal doxorubicin (Doxil)FDA Link 01/2020 - 02/2015
3	Galectin 1 (LGALS1)IBA 10/2019 - 04/2016
3	Carrier Proteins (Binding Protein)IBA 01/2018 - 01/2013
3	Estrogen Receptor alphaIBA 01/2018 - 10/2006
3	Topotecan (Hycamtin)FDA LinkGeneric 01/2018 - 01/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2017 - 04/2010
3	taxaneIBA 03/2016 - 01/2010

Therapy/Procedure

64	Therapeutics 03/2022 - 02/2009
44	Drug Therapy (Chemotherapy) 03/2022 - 02/2009
9	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 05/2013
9	Cytoreduction Surgical Procedures 10/2019 - 07/2009
8	Radiotherapy 01/2021 - 04/2012
6	Adjuvant Radiotherapy 01/2022 - 12/2011
6	Adjuvant Chemotherapy 08/2021 - 05/2016
3	Immunotherapy 07/2021 - 12/2019
3	Neoadjuvant Therapy 10/2019 - 09/2009